14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:ANTH
Delisted

Anthera Pharmaceuticals Stock Price (Quote)

NASDAQ Stock Exchange > Healthcare > Biotechnology
Open Broker Account
$0.000001
+0 (+0%)
At Close: May 27, 2022
Forecast Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $0.000001 $0.000001 Friday, 27th May 2022 ANTH stock ended at $0.000001. During the day the stock fluctuated 0% from a day low at $0.000001 to a day high of $0.000001.
90 days $0.000001 $0.000001
52 weeks $0.000001 $0.0850

Historical Anthera Pharmaceuticals prices

Date Open High Low Close Volume
May 02, 2019 $0.0909 $0.0925 $0.0802 $0.0849 15 877
May 01, 2019 $0.0880 $0.0970 $0.0850 $0.0921 30 777
Apr 30, 2019 $0.0720 $0.100 $0.0713 $0.0880 25 195
Apr 29, 2019 $0.0760 $0.0950 $0.0751 $0.0751 8 663
Apr 26, 2019 $0.0800 $0.0949 $0.0760 $0.0842 79 325
Apr 25, 2019 $0.0777 $0.0900 $0.0777 $0.0900 12 961
Apr 24, 2019 $0.0856 $0.0950 $0.0777 $0.0923 33 662
Apr 23, 2019 $0.0840 $0.0970 $0.0740 $0.0900 174 934
Apr 22, 2019 $0.0802 $0.0950 $0.0735 $0.0950 3 188
Apr 18, 2019 $0.0800 $0.0900 $0.0710 $0.0900 4 525
Apr 17, 2019 $0.0900 $0.0950 $0.0800 $0.0925 20 532
Apr 16, 2019 $0.0700 $0.0950 $0.0700 $0.0892 20 228
Apr 15, 2019 $0.0700 $0.0950 $0.0700 $0.0940 32 994
Apr 12, 2019 $0.0805 $0.0990 $0.0802 $0.0928 7 041
Apr 11, 2019 $0.0800 $0.0990 $0.0800 $0.0990 6 822
Apr 10, 2019 $0.0900 $0.0950 $0.0900 $0.0945 33 561
Apr 09, 2019 $0.0750 $0.0950 $0.0710 $0.0950 4 275
Apr 08, 2019 $0.0800 $0.0950 $0.0750 $0.0950 8 723
Apr 05, 2019 $0.0811 $0.100 $0.0810 $0.0822 38 546
Apr 04, 2019 $0.0850 $0.100 $0.0850 $0.0900 105 789
Apr 03, 2019 $0.0851 $0.0969 $0.0851 $0.0969 3 474
Apr 02, 2019 $0.0930 $0.0990 $0.0863 $0.0990 159 650
Apr 01, 2019 $0.0990 $0.0990 $0.0940 $0.0990 12 884
Mar 29, 2019 $0.0940 $0.0990 $0.0940 $0.0990 13 569
Mar 28, 2019 $0.100 $0.100 $0.0880 $0.0990 28 430
Click to get the best stock tips daily for free!

About Anthera Pharmaceuticals

Anthera Pharmaceuticals Anthera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. It develops Sollpura, a non-porcine investigational pancreatic enzyme replacement therapy that is in Phase III clinical trial for the treatment of patients with exocrine pancreatic insufficiency; and Blisibimod, which is in Phase II clinical trial for the treatment of B-cell mediated auto... ANTH Profile

Golden Star

Ticker Date Change Price
MLI Apr 19 10.86% $52.28
LPLA Apr 19 0.743% $262.59
DOOR Apr 18 0.160% $131.39
LNG Apr 17 0.389% $156.81
FCN Apr 16 2.95% $207.62
ELV Apr 16 5.28% $506.97
DXC Apr 08 0.767% $20.87
AKR Apr 05 5.63% $16.53
ITCI Apr 05 6.84% $68.44
SARK Mar 28 13.80% $26.88
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT